T-cell activator peptides and adjuvant
CoVac-1, developed and produced by the Good Manufacturing Practices (GMP) Peptide Laboratory at the Department of Immunology, University of Tübingen, Germany, is a peptide-based T-cell activator comprising six HLA-DR-restricted SARS-CoV-2 peptidesCoVac-1 peptides (250 µg/peptide) and XS15 (50 µg) were prepared as water-oil emulsion 1:1 with Montanide